Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta-analysis.

Yongxing BaoZeliang MaMeng YuanYang WangYu MenZhouguang Hui

Published in: Thoracic cancer (2022)

NCRT + S is the most efficient neoadjuvant treatment for resectable locoregional esophageal cancer. However, NCRT + S increases the risk of postoperative mortality but not morbidity.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
lymph node
radiation therapy
patients undergoing
liver metastases
cardiovascular events
risk factors
cardiovascular disease
coronary artery disease